| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OKYO Pharma Limited (OTCQB: EMMLF)
EMMLF Technical Analysis
5
| As on 19th May 2023 EMMLF STOCK Price closed @ 0.89 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.07 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EMMLFSTOCK Price
| Open | 0.89 | Change | Price | % |
| High | 0.89 | 1 Day | 0.88 | 8800.00 |
| Low | 0.89 | 1 Week | 0.87 | 4350.00 |
| Close | 0.89 | 1 Month | 0.87 | 4350.00 |
| Volume | N/A | 1 Year | 0.81 | 1012.50 |
| 52 Week High 0.11 | 52 Week Low 0.01 | ||||
OTCQB USA Most Active Stocks
| SURG | 1.80 | 23.29% |
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| FNMA | 3.16 | 4.98% |
| FMCC | 3.08 | 5.48% |
| BTCWF | 0.10 | 150.00% |
| BEGI | 0.00 | % |
| EFSH | 0.36 | -7.69% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| EMMLF Daily Charts |
EMMLF Intraday Charts |
Whats New @ Bazaartrend |
EMMLF Free Analysis |
|
|
EMMLF Important Levels Intraday
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
| RESISTANCE | 0.89 |
EMMLF Forecast November 2024
| 4th UP Forecast | 0.93 |
| 3rd UP Forecast | 0.92 |
| 2nd UP Forecast | 0.91 |
| 1st UP Forecast | 0.9 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | 0.87 |
| 3rd DOWN Forecast | 0.86 |
| 4th DOWN Forecast | 0.85 |
EMMLF Weekly Forecast
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.89 |
| 2nd UP Forecast | 0.89 |
| 1st UP Forecast | 0.89 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | 0.89 |
| 3rd DOWN Forecast | 0.89 |
| 4th DOWN Forecast | 0.89 |
EMMLF Forecast2024
| 4th UP Forecast | 2.59 |
| 3rd UP Forecast | 2.04 |
| 2nd UP Forecast | 1.71 |
| 1st UP Forecast | 1.37 |
| 1st DOWN Forecast | 0.41 |
| 2nd DOWN Forecast | 0.07 |
| 3rd DOWN Forecast | -0.26 |
| 4th DOWN Forecast | -0.81 |
OKYO Pharma Limited ( OTCQB USA Symbol : EMMLF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EMMLF Business Profile
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom. Address: 55 Park Lane, London, United Kingdom, W1K 1NA
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service